tradingkey.logo
tradingkey.logo
Search

Supernus Pharmaceuticals Inc Enters Asset Purchase Agreement With Navitor On April 1, 2026

ReutersApr 7, 2026 9:59 PM

- Supernus Pharmaceuticals Inc SUPN.O:

  • SUPERNUS PHARMACEUTICALS INC - ENTERS ASSET PURCHASE AGREEMENT WITH NAVITOR ON APRIL 1, 2026 - SEC FILING

  • SUPERNUS PHARMACEUTICALS INC - TO BUY ASSETS RELATED TO NV-5138 OR SPN-820 INCLUDING IP AND INVENTORY - SEC FILING

  • SUPERNUS PHARMACEUTICALS INC - PURCHASE PRICE INCLUDES PHASE 2B STUDY AND MILESTONE PAYMENTS UP TO $350 MILLION - SEC FILING

  • SUPERNUS PHARMACEUTICALS INC - AGREEMENT INCLUDES FIVE-YEAR NON-COMPETE AND NON-SOLICITATION COVENANT - SEC FILING

Source text: [ID:n0001104659-26-040497]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI